Solid Tumor Clinical Trials

A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2017 clinical trials
A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations

An open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-306 in advanced or metastatic solid tumors with IDH mutation.

  • 0 views
  • 13 Mar, 2022
  • 8 locations
A Study of Dose Escalation of IBI321 in Patients With Advanced Solid Tumors

This first-in-human open-label, multicenter, dose-escalation and expansion study is designed to evaluate the safety, tolerability, and primary efficacy of IBI321 in participants with locally advanced, recurrent, or metastatic incurable tumors for whom standard therapy does not exist, has proven to be ineffective or intolerable.

  • 0 views
  • 05 Aug, 2021
  • 1 location
A Study of the Safety and Tolerability of IBI321 in Patients With Advanced Solid Tumors

This first-in-human open-label,dose-escalation study is designed to evaluate the safety, tolerability, and primary efficacy of IBI321 in participants with locally advanced, recurrent, or metastatic incurable tumors for whom standard therapy does not exist, has proven to be ineffective or intolerable.

  • 0 views
  • 02 Aug, 2021
  • 1 location
Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

The main purpose of this study was to assess the safety, tolerability, and efficacy when combining SHR-1701 and BP102 in participants with certain cancers. This study was conducted in 2 phases, Phase Ib and Phase II.

  • 0 views
  • 22 Aug, 2021
  • 1 location
Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

This is an open-label, multicenter, Phase 1a study to evaluate the safety, tolerability, PK and preliminary efficacy of AN2025 and AN0025 in double or triple combination treatments with Atezolizumab in patients with locally advanced/metastatic tumors.

  • 0 views
  • 22 Mar, 2022
  • 4 locations
A Study of HMPL-295S1 in Patients With Advanced Malignant Solid Tumors

The objective of this study is to evaluate the safety, tolerability and PK profile of HMPL-295S1 and determine MTD and/or RP2D in patients with advanced malignant solid tumor. It will be

  • 0 views
  • 11 Sep, 2021
  • 1 location
A Study to Evaluate YH003 in Subjects With Advanced Solid Tumors

(RP2D) of YH003 in subjects with advanced solid tumors.

  • 0 views
  • 13 Mar, 2022
  • 1 location
ZZ06 in Adult Patients With Advanced EGFR Positive Solid Tumor Malignancies

, pharmacokinetics (PK), immunogenicity, pharmacodynamics (PD) and anti-tumor activity of ZZ06 as a single agent in adult participants with advanced solid tumors.

  • 6 views
  • 27 Apr, 2021
  • 4 locations
A Phase I Study of JS108 in Patients With Advanced Solid Tumors

This is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, PK profile and efficacy of JS108 for patients with advanced solid tumors. This study

  • 0 views
  • 19 Apr, 2022
  • 3 locations
REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors (COMBINE-EGFR-1)

patients with advanced solid tumors Dose Expansion: • To assess the preliminary efficacy of REGN7075 in combination with cemiplimab within selected advanced solid tumor-specific cohorts, as

  • 4 views
  • 05 Apr, 2022
  • 6 locations